Actively Recruiting
Breathlessness Diagnostics in a Box BiaB for Primary Care A Multi-country Quality Improvement Project Using a Randomized Stepped-wedge Design
Led by General Practitioners Research Institute · Updated on 2026-01-07
900
Participants Needed
3
Research Sites
N/A
Total Duration
On this page
Sponsors
G
General Practitioners Research Institute
Lead Sponsor
A
AstraZeneca
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating whether the Breathlessness diagnostics in a Box BiaB tool can shorten the time to diagnosis for patients experiencing breathlessness compared to usual care. This prospective, interventional study uses a stepped-wedge cluster design in general practice settings across the Netherlands, Spain, and Portugal. The main goal is to see if BiaB speeds up diagnosis, with secondary aims to identify more cases of chronic obstructive pulmonary disease COPD and cardiovascular disease CVD, and to assess the tools usability and efficiency. The study involves 45 general practice sites that start with a usual care period and sequentially transition to using the BiaB tool. Patients receive care as part of their regular visits, either through standard diagnostic procedures or with support from BiaB. No additional treatments are mandated by the study. Each site participates for 40 weeks, and data are gathered from routine clinical visits, electronic medical records, and questionnaires completed by patients and healthcare professionals. Participants attend a single study visit and may complete up to four quarterly questionnaires over a follow-up period lasting up to one year. Researchers measure the time from first presentation of breathlessness to diagnosis, the number of new COPD and CVD diagnoses, and the usability of the BiaB tool. Data are collected continuously during the usual care and intervention phases, allowing comparison of outcomes between these periods.
CONDITIONS
Brief Title
"Breathlessness Diagnostics in a Box" (BiaB) for Primary Care. A Multi-country Quality Improvement Project Using a Randomized Stepped-wedge Design
Who Can Participate
Eligibility Criteria
You may qualify if you...
- At least 18 years old at the time of signing informed consent
- Presenting with undiagnosed breathlessness (dyspnea)
- Have existing diseases that cause breathlessness but experience new or worsening breathlessness that may be caused by other undiagnosed conditions
- Healthcare professional has doubts or requires additional tests to confirm or suspect new diagnoses related to breathlessness
You will not qualify if you...
- Acute worsening of a previously diagnosed chronic disease with no suspicion of other comorbidities
- Unable to understand and sign the written consent form
Research Team
J
Janwillem WH Kocks, Prof. Dr.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here